BCV Asset Management
QUIT icon

BCV Asset Management’s Achieve Life Sciences QUIT Stock Holding History

BCV Asset Management’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$214K Sell
26,315
-50
-0.2% -$358 0.01% 108
2026
Q2 		$165K Hold
26,365
– – 0.01% 112
2026
Q1 		$77.5K Buy
+26,365
New +$117K ﹤0.01% 115

Other funds holding QUIT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

BCV Asset Management's QUIT Position: Q3 2026 in Review

BCV Asset Management reduced its Achieve Life Sciences (QUIT) stake by 0.19% in Q3 2026, selling an estimated $358 and leaving 26,315 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #108.

BCV Asset Management first reported a position in QUIT in Q1 2026 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • BCV Asset Management held 26,315 shares of Achieve Life Sciences worth $214K as of Q3 2026.
  • BCV Asset Management sold 50 Achieve Life Sciences shares in Q3 2026, an estimated $358.
  • Achieve Life Sciences made up 0.01% of BCV Asset Management's portfolio in Q3 2026, its #108 holding.
  • BCV Asset Management first reported a position in Achieve Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • 83 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on BCV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.